Skip to content
DE

Does castor oil help eyelashes grow?

Clinical review pending

Castor oil may condition existing lashes, but growth is a separate claim. What eyelid studies show, how bimatoprost differs, and when lash loss needs assessment.

Loose gray shapes enter a clear prism and become three blue light bands.

Castor oil is a fatty-acid-rich plant oil used in cosmetics as a conditioning ingredient. It has not been shown convincingly to make healthy eyelashes grow. An oil coating can change the appearance of existing lashes, but a measurable reduction in lash breakage is a separate claim that remains poorly studied. Small trials of eyelid application have mainly examined blepharitis, an inflammatory eyelid condition, rather than cosmetic growth in healthy lashes. Hair-oil review

What castor oil is and why people use it on eyelashes

Castor oil comes from the seeds of Ricinus communis. It appears in a range of cosmetic products. In 2025, the Cosmetic Ingredient Review expert panel concluded that the ingredients it assessed were safe under the cosmetic uses and concentrations described in its review. That is not FDA approval, and it does not establish that any castor oil product is suitable for direct use in the eye. Safety assessment FDA cosmetics information

Ricinoleic acid is castor oil’s main fatty acid. A 2012 study in cells and mice found that it activates prostaglandin EP3 receptors involved in intestinal and uterine muscle contraction. This helps explain effects of oral castor oil, but it does not demonstrate an effect on eyelash follicles. Study

Products differ in how they are made, what else they contain, and where they are intended to be used. Jamaican black castor oil is made using roasted seeds; there is no established advantage of that preparation for eyelashes. Bimatoprost, by contrast, is a prescription drug with clinical evidence for eyelash growth. Castor oil is not an equivalent treatment.

What castor oil may do at the lash line

The plausible cosmetic effects are local: coating and conditioning existing hairs. The available studies do not establish a systemic benefit or reliable stimulation of healthy eyelash growth from applying castor oil to the lash line.

Local effects on lashes and eyelids

An oil coating may make existing lashes look shinier. How much castor oil reduces lash breakage or moisture loss has received little clinical study. A small, four-week blepharitis trial found improvements at the treated eyelid margin, including an improvement in the clinical sign of lash loss. That finding is worth preserving, but it does not show that castor oil lengthens or thickens healthy lashes. The EP3 mechanism studied in the bowel and uterus does not establish that effect either. Blepharitis trial Mechanism study

Whether it reaches the bloodstream

The cited studies do not adequately quantify systemic absorption after cosmetic application to the lash line. They do not establish an anti-inflammatory effect throughout the body from this use. Equally, a lack of absorption data is not a guarantee that every product or application method is harmless.

What the research supports

The descriptions below distinguish clinical evidence for castor oil from evidence for prescription prostaglandin analogs. They are qualitative summaries, not a formal GRADE assessment. Useful distinctions include strong, moderate, limited, animal-only, and anecdotal evidence; each rating needs to be read alongside the specific population and outcome.

Eyelash growth: anecdotal claims, without convincing clinical evidence

The cited clinical work does not demonstrate cosmetic growth of healthy eyelashes from castor oil. Studies of latanoprost and bimatoprost concern different drugs; their results cannot be transferred to ricinoleic acid simply because all involve some part of prostaglandin signaling. A shared biological pathway can generate a hypothesis, but it does not make the treatments interchangeable. Latanoprost Bimatoprost mechanism Bimatoprost trial Ricinoleic acid

Conditioning and a fuller appearance: limited evidence

Castor oil is used as an emollient, a conditioning ingredient. A review of hair oils found weak evidence for improved luster, but no strong evidence for hair growth. Findings about hair in general offer only limited support for claims about eyelashes specifically. A glossy coating that makes lashes look more prominent is not evidence of new hairs. Review

Blepharitis and eyelid health: promising but limited clinical evidence

An investigator-masked trial published in 2021 enrolled 26 people with blepharitis. One randomly selected eye received topical castor oil treatment for four weeks; the other served as a control. Several eyelid findings improved, including crusting and the clinical sign of lash loss, and no adverse events were reported during that short period. It is an encouraging result from a small study, not a demonstration of long-term safety or healthy-lash growth. A related review discusses potential applications in blepharitis, meibomian gland dysfunction, and dry eye, but does not validate every cosmetic self-care routine. Trial Review

Castor oil versus bimatoprost: different levels of evidence

In a randomized trial, bimatoprost improved eyelash length, thickness, and darkness compared with its inactive vehicle. FDA approval for eyelash hypotrichosis, or inadequate eyelashes, followed in 2008. Potential adverse effects include irritation and changes in pigmentation or tissues around the eye. A more recent prospective study examined prostaglandin eye drops in people with glaucoma or elevated eye pressure; its numerical risk estimates cannot simply be applied to cosmetic use along the lash line. Bimatoprost has direct clinical efficacy evidence that castor oil lacks, while still requiring an individual discussion of benefits and risks. Efficacy trial Safety review Glaucoma study

Using castor oil near the lashes: eye precautions

Cosmetic routines are not established clinical protocols. There is no validated dose or application schedule for castor oil to grow eyelashes, and safety depends on the formulation and how close it comes to the eye.

Where should it be applied?

Near the eyes, use only a product specifically intended for that area and follow its directions. Household oil is not a sterile ophthalmic preparation. If your eyes are irritated, you have conjunctivitis, or you have recently had eye surgery, seek eye-care advice before adding a product. A research protocol for treating blepharitis should not be treated as a general eyelash-care instruction. Blepharitis trial

Frequency and checking for a reaction

An optimal frequency for cosmetic lash conditioning has not been established clinically. Trying a product on your arm cannot guarantee that it will be tolerated around the eye, and it does not replace allergy assessment when one is needed. Contact allergy to castor-oil-containing products has been reported, but case reports do not establish how often it happens. Suitable safety data for this cosmetic routine in children are lacking. Avoid getting the product into the eyes. Contact-allergy report

Who might consider it, and when to avoid it

For conditioning intact lashes, choose a product intended for the eye area. Irritated or persistently dry eyelid margins deserve assessment for an underlying condition. If the goal is longer or denser lashes, castor oil does not have convincing evidence that it delivers that result.

Avoid self-directed use at the lash line in these circumstances:

  • You have active eye irritation or conjunctivitis, or recently had eye surgery or another procedure.

  • You have a known allergy to castor oil or an ingredient in the product. A history of contact dermatitis from another plant oil is a reason to check the specific product, not proof of an allergy to every oil. Contact-allergy report

  • You are wearing contact lenses during application, which can expose the lenses to the product.

  • You want to use it on a child. This cosmetic application has not been adequately studied, so seek professional advice first.

  • You expect it to treat inadequate lash growth. A prescription option such as bimatoprost has direct clinical evidence when treatment is appropriate; castor oil has not been shown to be a substitute.

Lash loss after chemotherapy, with alopecia areata, or in association with thyroid disease needs clinical assessment. The same applies to thinning associated with chronic blepharitis or recent eye surgery. Depending on the history, a dermatologist, eye-care professional, or primary care clinician can investigate. Switching to another topical oil does not address the underlying question.

Side effects, FDA status, and the bimatoprost comparison

FDA status. A cosmetic safety assessment by Cosmetic Ingredient Review is not drug approval. The FDA does not require premarket approval for most cosmetic ingredients. Bimatoprost, sold as Latisse, is approved in the US for eyelash hypotrichosis. That approval does not extend to castor oil or establish that it has the same effect. FDA Latisse prescribing information

Possible adverse effects. Castor-oil-containing products can cause contact allergy. A report involving a castor-oil-containing wound dressing documents a reaction, but cannot tell us the incidence at the lash line. Stop using a product if it causes burning, redness, or visual disturbance. Persistent symptoms warrant eye-care assessment; significant pain or vision changes should be assessed promptly. Case report

Interactions and product differences. Bimatoprost is a drug with demonstrated activity; castor oil is a cosmetic ingredient. Their combined use has not been well studied. If you use bimatoprost or another eye medication, discuss additional eyelid products with the treating clinician. This is a precaution about limited combination data, not a claim that castor oil has a proven drug interaction. Review Prescribing information

Pregnancy and breastfeeding. Controlled safety data for cosmetic lash-line use are lacking. The intestinal and uterine effects of swallowed castor oil should not be assumed to occur after topical cosmetic use; equally, the difference in exposure does not establish safety. Ask a clinician if you are considering a new product during these stages. Mechanistic study

Blood tests when investigating eyelash loss

New or pronounced lash loss starts with an examination of the eyelids, skin, and hair. Thyroid disease or a nutrient deficiency may be relevant alongside local conditions and other causes. Blood tests are useful when the history and examination suggest a reason to order them, not as a standard requirement before using any conditioning product. American Academy of Dermatology

  • TSH: Often a useful first test when thyroid dysfunction is suspected. A normal result makes most primary thyroid disorders unlikely, though it does not address every possible thyroid or pituitary problem. American Thyroid Association

  • Free T3 and free T4: Follow-up tests depend on the findings. Free T3 is generally not helpful for diagnosing hypothyroidism, and a TSH at the upper end of its reference interval is not, by itself, a reason to order a broad hormone panel. American Thyroid Association

  • Ferritin: May be part of an assessment for iron deficiency. A low value alone does not prove that iron deficiency is causing eyelash loss.

  • Vitamin D: Associations with some hair disorders do not establish a general cause of lash loss. They do not justify routine testing or supplementation for everyone.

The examination should guide which tests are needed. A confirmed deficiency deserves appropriate treatment, but correcting it cannot guarantee that eyelashes will regrow.

When eyelash loss needs medical attention

Lash loss linked to chemotherapy, alopecia areata, thyroid disease, recent eye surgery, or chronic blepharitis calls for a diagnosis rather than a new cosmetic oil. A primary care clinician, dermatologist, or eye-care professional can help distinguish local irritation from a wider health issue. Cosmetic conditioning of intact lashes and treatment of unexplained lash loss are different goals.

Alternatives for eyelash concerns

Depending on the cause, the next step may be suitable cosmetic care, a prescription treatment, or management of an underlying condition. These options serve different purposes.

  • Castor oil: Limited evidence supports conditioning-related effects, with no convincing demonstration of healthy eyelash growth. Product suitability for the eye area and individual tolerance matter.

  • Bimatoprost (Latisse): A prescription treatment with clinical evidence for eyelash hypotrichosis. A clinician can weigh likely benefit against possible eye and surrounding-tissue changes. Trial Safety review

  • Treatment of an identified cause: Confirmed iron deficiency or thyroid disease needs appropriate management. Whether lashes regrow depends on whether that condition caused the loss and whether other factors are involved.

  • Other cosmetic lash conditioners: Products without prostaglandin analogs may be an option for conditioning. Their growth claims and tolerability still need separate consideration; switching oils does not automatically eliminate allergy risk.

If thyroid disease or iron deficiency is contributing to lash loss, neither castor oil nor bimatoprost replaces treatment of that condition. Bimatoprost belongs in the comparison because it has clinical evidence for lash growth, but the best choice still depends on what is causing the problem.

Frequently asked questions

Does castor oil actually make eyelashes grow?

Convincing clinical evidence for growth of healthy eyelashes is lacking. Ricinoleic acid’s effects in the bowel and uterus do not demonstrate stimulation of eyelash follicles. An oil film may change the appearance of existing hairs; a benefit for blepharitis-related lash loss would also be a different outcome from making healthy lashes longer. Mechanism Hair-oil review

Is castor oil FDA-approved for eyelash growth?

Castor oil is used in cosmetics, but it is not an FDA-approved eyelash-growth drug. Bimatoprost, sold as Latisse, is a prescription prostaglandin analog approved for eyelash hypotrichosis, with clinical evidence of growth effects. Approval of one product does not validate claims for the other. Trial

What does research say about castor oil for eyelashes?

Castor oil has an established cosmetic role as an emollient, but research does not establish that it grows healthy lashes. A small randomized trial published in 2021 found improvements in blepharitis after application around the eye, including a clinical sign of lash loss. That is a promising eyelid-health finding, not proof of cosmetic lengthening or thickening. Trial

What side effects can occur when it is used on eyelashes?

Local irritation and contact allergy are possible. Stop if a product causes burning, redness, or visual symptoms, and seek eye-care advice if symptoms persist. Significant pain or vision changes need prompt assessment. Case reports establish that allergy can occur but do not quantify its frequency in eyelash use. Contact-allergy report

Who should avoid using castor oil on eyelashes?

Avoid self-directed use if the eyes are inflamed, after eye surgery, or if you have a known allergy to the product. Do not apply it while wearing contact lenses. A cosmetic castor-oil routine for children has not been adequately studied.

Is long-term use at the lash line safe?

The small blepharitis trial lasted only four weeks. It did not establish the long-term safety of a daily cosmetic routine, particularly across different formulations and application methods. Absence of adverse events in a short trial cannot exclude less common or delayed problems. Trial

Is bimatoprost better than castor oil for eyelashes?

For actual eyelash growth, bimatoprost has clinical evidence that castor oil lacks. It is not risk-free: possible concerns include loss of fat around the eye and changes in iris pigmentation. The rates and context depend on the preparation and use, so prescription treatment should involve an individual benefit-risk discussion. Efficacy trial Safety review

Which blood markers should I check if I am losing lashes or hair?

Start with an assessment of the cause. TSH or iron studies may be useful depending on the findings. A blanket panel of TSH, free T3, free T4, ferritin, and vitamin D is not necessary for everyone, and normal blood results do not exclude local eyelid disease. American Academy of Dermatology American Thyroid Association

Sources and further reading